Recorded device evidence

PICOCLAMP (K230281): indications, design and recorded evidence

The acquired K230281 file contains product-specific indications and users, design and operating principle, non-clinical evidence actually described sections. Compare these dated manufacturer statements with your own indication and design before commissioning evidence work. They describe this submission; they do not prescribe your testing, validate performance independently or establish a suitable predicate.

Evidence retrieved 2026-10-07. Source versions and topic-specific limits are listed below.

Computed exact-code research

This decision beside its recorded product-code cohort

The 2021–2025 complete-year cohort contains 14 selected decisions under primary code DXC. 14 have valid reported receipt/decision pairs; 0 pairs are missing or invalid.

No quartiles are displayed: this complete-year cohort has fewer than 20 valid pairs.

The table shows the named decision and up to four latest exact-code research records through 2026-09-27. It can include partial-year records outside the complete-year cohort. The quartiles above use the full stated cohort, not this displayed selection.

Research recordRecorded deviceReceipt → decisionCalendar elapsed daysRecorded submission type
K230281 ↗ · this pagePICOCLAMP2023-02-01 → 2023-10-23264Traditional
K262086 ↗PreludeSYNC™ Radial Compression Device2026-06-22 → 2026-07-2230Special
K260105 ↗Fogarty Spring Clips, Handleless Clamps, and Clamp Inserts2026-01-13 → 2026-06-05143Traditional
K252772 ↗Arc Adjustable Radial Cuff Compression Device2025-09-02 → 2026-05-22262Traditional
K254060 ↗Life Saving Tourniquet2025-12-17 → 2026-04-03107Traditional

Use this comparison: select a record to investigate, read its actual indications and design, and document differences. A shared code or elapsed period cannot establish its relevance to your device.

Calendar elapsed days are not active FDA review time, a promised schedule or a success probability. The selection includes only the stated recorded decisions, not all applications. Latest records can postdate the named historical decision and are contextual research, not its predicates. Shared codes, summaries and observed records do not prove equivalence, current market availability, buyer applicability or predicate suitability.

Calculation, selection and source versions

Reuse the complete-endpoint exact-primary-code, documented SE-decision cohort and its stated cutoff/window. Retain its type-7 quartiles only when at least 20 valid date pairs are present. Independently subtract the named official record’s receipt date from its decision date; missing or negative pairs remain unknown. Show up to four latest exact-code research records, excluding the named ID. Parent analysis hash, source snapshots and calculation versions are retained.

Calculation: fda-named-decision-cohort-context-1; cutoff 2026-09-27; 0 parent records excluded; units record counts; calendar elapsed days.

Source snapshots: 5a86994ba49a37e71e09be96803fd51981c6c43eaa96caab41aea2b188bfe002.

Read beyond the decision row

Recorded evidence and differences to investigate

The summary is manufacturer-submitted context hosted by FDA. Negative/no-study statements are preserved. Evidence themes are not binding legal requirements.

Short opening excerpts identify the source sections. Read the linked original for the full study context, negative statements, tables and limitations. Public quotations are limited to 120 words per acquired summary; the internal evidence packet retains exact section ranges for review.

Indications and users

K230281 · PDF page 6 ↗ Source 2

A surgical instrument used to occlude a blood vessel temporarily.

VI.   COMPARISON OF TECHNOLOGICAL CHARACTERISTICS WITH THE
PREDICATE DEVCE
In terms of technological characteristics, PICOCLAMP does not completely share them
with the predicate device.

The excerpt is shortened at a complete statement. Read the complete section in the original PDF before interpreting the evidence.

Compare with your product: Compare the recorded indication, population, body site and use environment with your proposed label. Record each change instead of assuming the primary code settles intended use.

Design and operating principle

K230281 · PDF page 5 ↗ Source 3

PICOCLAMP    is    Ethylene    Oxide    sterile    single-use    hemostasis    clamp    consisting    of
Polyetheretherketone (PEEK) and stainless steel (SUS series).  PICOCLAMP is designed for use
during   surgery   to   temporarily   occlude   blood   vessels   during   the   anastomosis   process.

The excerpt is shortened at a complete statement. Read the complete section in the original PDF before interpreting the evidence.

Compare with your product: Compare physical design, materials, energy, accessories and operating principle with your design. Ask which documented differences change the evidence scope.

Non-clinical evidence actually described

K230281 · PDF page 7 ↗ Source 4

Since  no  guidance  documents  or  FDA  recognized  consensus  standards  exist  for  the
device  type,  structural  and  dimensional           confirmation,      clipping  power testing,        ability  for
repeated  clamp  opening  and  closing,  and  resistance  to  dislodgement  testing                            were
conducted   as   performance   testing.

The excerpt is shortened at a complete statement. Read the complete section in the original PDF before interpreting the evidence.

Compare with your product: Treat these as documented evidence themes in this case, including any limitations or negative statements. Ask which protocols, design inputs and acceptance rationale would be justified for your product; these excerpts are not a mandatory test panel.

Extraction selection and limits

Select observed whole-line section headings or explicit colon-delimited inline labels on readable PDF pages, including the explicitly documented heading-spacing variants in this parser version. Preserve the original heading, character ranges and layout; do not repair excerpt text. Exclude letter boilerplate and uncertain pages. Stop at observed table headings; do not infer table columns or scalar results from layout text. Multi-column or suspicious split-numeric excerpts are excluded until reviewed alternate extraction is available. Original layout records remain retained; any alternate text has its own extractor-version locator and requires original-page review. For each dimension, prefer usable versioned alternate text where available, selecting its longest usable excerpt; otherwise select the longest usable original-layout excerpt. Ties preserve source order. Bounded to 64 PDF pages and 3,500 characters per section. This is a selection, not a complete dossier analysis.

Excluded extraction items: {}.

Known facts and deciding inputs

Known context: US. Confirm the organisation’s role, relevant activities and markets against the cited criteria.

Source factRecorded valueWhat to check
510(k) identifierK230281 [1]Dated official record fact; not proof of current commercial availability or applicability to another device.
Generic device categoryPICOCLAMP [1]Dated official record fact; not proof of current commercial availability or applicability to another device.
Recorded applicantKono Seisakusho Co., Ltd. [1]Dated official record fact; not proof of current commercial availability or applicability to another device.
FDA product codeDXC [1]Dated official record fact; not proof of current commercial availability or applicability to another device.
Decision date2023-10-23 [1]Dated official record fact; not proof of current commercial availability or applicability to another device.
Recorded decision codeSESE [1]Dated official record fact; not proof of current commercial availability or applicability to another device.
Submission typeTraditional [1]Dated official record fact; not proof of current commercial availability or applicability to another device.
Receipt date2023-02-01 [1]Dated official record fact; not proof of current commercial availability or applicability to another device.

Prepare a differences and evidence worksheet

Use this checklist to gather your business or product details before speaking with a specialist. The items below explain what to record and suggest useful supporting documents. You can add your own answers in the editable project brief.

  1. Indications and users — what differs in our product?

    Compare the recorded indication, population, body site and use environment with your proposed label. Record each change instead of assuming the primary code settles intended use.

    Useful evidence: Our proposed indication, user/population and use environment beside this exact recorded indication.

  2. Design and operating principle — what differs in our product?

    Compare physical design, materials, energy, accessories and operating principle with your design. Ask which documented differences change the evidence scope.

    Useful evidence: Design description, materials/components, accessory list and a differences matrix.

  3. Non-clinical evidence actually described — what differs in our product?

    Treat these as documented evidence themes in this case, including any limitations or negative statements. Ask which protocols, design inputs and acceptance rationale would be justified for your product; these excerpts are not a mandatory test panel.

    Useful evidence: Existing protocols/results and design-specific evidence gaps, with standard editions and scope reviewed separately.

Work packages and dependencies

What needs to happen first

Questions for providers

Sources and data dates

Read the official document in context. The audit details identify the precise locators and preserved versions used for this page.

FDA openFDA — 510(k) decision records ↗

2026-10-05 · retrieved 2026-10-06

Audit details: precise locators and snapshot identifiers

Source key D01 · snapshot 5a86994ba49a37e71e09be96803fd51981c6c43eaa96caab41aea2b188bfe002

  • [1] device-510k-0001-of-0001.json:results[128857] · record a72615a288ccc561c1a84d7b02c2a2544b61075f54ef20af10f026d586657509
  • [5] Complete results array / fda-decision-context:K230281 · record whole dataset partition

FDA 510(k) summary — K230281 ↗

Sun, 29 Oct 2023 22:08:34 GMT · retrieved 2026-10-07

Audit details: precise locators and snapshot identifiers

Source key D02 · snapshot d92d9aba98791e07395149cd8e8d30cc0c89de24366baca6b724073aeff82e6d

  • [2] PDF page 6 · record c4391c90bd719aa927539c657ebead5cf869f851b53b48405932dc8ed3fe4cb4
  • [3] PDF page 5 · record 21d4608ab89cf66fde09c02f28e047f610e6123ec4fd6d2240c49f1d2c9b8857
  • [4] PDF page 7 · record e953c9b06fd464af8632f9ca533d3bd98e3a60e977c2d583df011d4ea9186421

Prepare an editable project brief

Confirm the facts, scope and contact preference before sharing your project. Preparing this page sends no provider outreach.

Choose work packages to discuss

Compare FDA 510(k) Submission Services

Biocompatibility Testing (ISO 10993 Program) · Sterilization + Microbiology Validation